bisacodyl has been researched along with framycetin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Beschke, K; Hankwitz, R; Jauch, R; Pelzer, H | 1 |
Epping, J; Fuchshofen, M; Richter, E | 1 |
3 other study(ies) available for bisacodyl and framycetin
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Bis-(p-hydroxyphenyl)-pyridyl-2-methane: The common laxative principle of Bisacodyl and sodium picosulfate.
Topics: Administration, Oral; Adult; Animals; Bisacodyl; Cathartics; Constipation; Cresols; Feces; Female; Germ-Free Life; Guinea Pigs; Humans; Hydrolysis; Intestines; Male; Middle Aged; Neomycin; Picolines; Rats; Suppositories; Time Factors | 1975 |
[Enterohepatic circulation in liver diseases].
Topics: Animals; Barbiturates; Bile Acids and Salts; Biotransformation; Bisacodyl; Chloramphenicol; Cholestasis; Digitoxin; Enterohepatic Circulation; Humans; Liver Cirrhosis; Liver Diseases; Neomycin; Phenytoin; Rats; Spironolactone | 1980 |